Clinical Research

Informed Consent in Clinical Trials: Process, Elements & Special Situations


Informed consent is the ethical heart of every clinical trial — and a guaranteed exam question. The single most important idea: consent is a process, not a signature. A signed form is only the documentation of a conversation in which the subject freely agreed to take part.

Three components of valid informed consent Information Full disclosure of all relevant trial aspects Comprehension Subject understands the information given Voluntariness Free choice — no coercion / undue influence Valid informed consent Ethical basis: “respect for persons” (Belmont) · documented by a signed & dated ICF Governed by ICH-GCP 4.8 and the NDCT 2019 Fifth Schedule
All three components — information, comprehension and voluntariness — must be present for consent to be valid.

Definition

Per GCP 1.28, informed consent is “a process by which a subject voluntarily confirms willingness to participate, after being informed of all aspects relevant to the decision.” It is documented by a signed and dated informed consent form (ICF).

Three essential components

ComponentMeaning
InformationAdequate disclosure of all relevant trial aspects.
ComprehensionThe subject understands the information given.
VoluntarinessA free decision, without coercion or undue influence.

Essential elements to disclose (GCP 4.8.10)

  • That the trial is research; its purpose, treatments and the probability of randomisation; and the procedures (including any invasive ones).
  • Foreseeable risks (including to embryo/foetus/nursing infant) and expected benefits — or a statement that there are none.
  • Alternative treatments; compensation and treatment for trial-related injury; any payment or expenses.
  • Voluntary participation — the right to refuse or withdraw at any time without penalty.
  • Confidentiality, with direct access to records by monitor/auditor/EC/regulator; that new information will be shared; contact persons; trial duration; and the number of subjects.

Documentation & process

  • The ICF is approved by the Ethics Committee, written in a language the subject understands, with no coercive or exculpatory language.
  • It is signed and dated by the subject (and by the person obtaining consent) before any trial procedure; a copy is given to the subject.
  • Re-consent is required on new safety information or protocol amendments.
  • In India, audio-visual recording of the consent process is required (NDCT) for vulnerable populations / specified trials.

Special situations

SituationSafeguard
Illiterate subjectAn impartial witness is present throughout and also signs & dates the ICF.
Vulnerable (child, mentally ill, unconscious)Consent by a Legally Acceptable Representative (LAR) + the subject’s assent where possible.
ChildrenParental/guardian consent + the child’s assent.
EmergencyWaiver under strict conditions, with prior EC approval.
Exam tip: consent = a voluntary process with three components — information, comprehension, voluntariness. Obtained before any procedure; signed & dated ICF, copy to subject. Illiterate → impartial witness; vulnerable → LAR + assent. AV recording in India for vulnerable subjects; re-consent on new information. Governed by GCP 4.8 and the NDCT 2019 Fifth Schedule.

Treat consent as a conversation you must be able to prove happened properly: full disclosure, genuine understanding, a free choice — documented, witnessed where needed, and refreshed whenever the facts change. That mindset answers every short note and viva on the topic.

Share

Clinical Research
← All articles